CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $13.11B, above the global median of $1.15B
- PositionCurrent ratio is 1.14×, lower than 95% of its Diagnostics & Research peers (median 2.76×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.11BUSDvs all stocks (USD)
Trailing P/E
74.89xvs Diagnostics & Research peers
Revenue (TTM)
8.27BUSDvs all stocks (USD)
Profit Margin
2.10%vs Diagnostics & Research peers
Beta
1.22xvs all stocks
52-Week Change
21.75%vs all stocks
Market Capitalization
13.11BUSDvs all stocks (USD)
Enterprise Value
15.96BUSDvs all stocks (USD)
Trailing P/E
74.89xvs Diagnostics & Research peers
Forward P/E
14.32xvs Diagnostics & Research peers
PEG Ratio
-2.65xvs Diagnostics & Research peers
Price to Sales (TTM)
1.59xvs Diagnostics & Research peers
Price to Book (MRQ)
1.40xvs Diagnostics & Research peers
Enterprise to Revenue
1.93xvs Diagnostics & Research peers
Enterprise to EBITDA
12.23xvs Diagnostics & Research peers
Gross Margin
23.50%vs Diagnostics & Research peers
Profit Margin
2.10%vs Diagnostics & Research peers
Operating Margin
9.19%vs Diagnostics & Research peers
Return on Assets (TTM)
3.51%vs Diagnostics & Research peers
Return on Equity (TTM)
1.84%vs Diagnostics & Research peers
Revenue (TTM)
8.27BUSDvs all stocks (USD)
Revenue per Share (TTM)
106.81USDUpdated Jul 19, 2026Quarterly Revenue Growth
0.90%vs Diagnostics & Research peers
Gross Profit (TTM)
2.09BUSDvs all stocks (USD)
EBITDA (TTM)
1.30BUSDvs all stocks (USD)
Net Income (TTM)
173.28MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-34.90%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
934.97MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
809.34MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
8.25BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.08BUSDFY2025 · Dec 31, 2025Gross Profit
2.18BUSDFY2025 · Dec 31, 2025Operating Income
1.01BUSDvs all stocks (USD)
Pre-tax Income
252.47MUSDFY2025 · Dec 31, 2025Income Tax Expense
23.13MUSDFY2025 · Dec 31, 2025Net Income
229.34MUSDFY2025 · Dec 31, 2025EBIT
440.57MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.39BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
780.14MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
7.11MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
188.11MUSDFY2025 · Dec 31, 2025EPS (Basic)
2.73USDFY2025 · Dec 31, 2025EPS (Diluted)
2.71USDFY2025 · Dec 31, 2025Basic Shares Outstanding
78.42MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
78.42MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
229.34MUSDFY2025 · Dec 31, 2025Operating Cash Flow
540.78MUSDFY2025 · Dec 31, 2025Free Cash Flow
366.57MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
647.29MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
229.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
383.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-128.92MUSDFY2025 · Dec 31, 2025Stock-based Compensation
102.04MUSDFY2025 · Dec 31, 2025Other Non-cash Items
53.43MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-169.32MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
71.22MUSDFY2025 · Dec 31, 2025Capital Expenditures
-174.21MUSDFY2025 · Dec 31, 2025Net Acquisitions
-2.54MUSDFY2025 · Dec 31, 2025Purchase of Investments
-19.87MUSDFY2025 · Dec 31, 2025Sale of Investments
9.09MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-187.53MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
50.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-79.76MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-750.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.22MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-780.98MUSDFY2025 · Dec 31, 2025Shares Outstanding
76.60MSharesUpdated Jul 19, 2026Float Shares
76.27MSharesUpdated Jul 19, 2026Shares Short
2.99MSharesUpdated Jul 19, 2026Short Ratio
2.51daysvs all stocks
Short % of Shares Outstanding
4.38%vs all stocks
% Held by Insiders
0.44%vs all stocks
% Held by Institutions
108.41%vs all stocks
Total Cash (MRQ)
765.16MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
9.99USDUpdated Jul 19, 2026Total Debt (MRQ)
3.54BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3810xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.14xvs Diagnostics & Research peers
Book Value per Share (MRQ)
121.41USDUpdated Jul 19, 2026Total Assets
16.27BUSDvs all stocks (USD)
Total Current Assets
3.50BUSDFY2025 · Dec 31, 2025Total Liabilities
7.08BUSDFY2025 · Dec 31, 2025Total Non-current Assets
12.77BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
3.88BUSDFY2025 · Dec 31, 2025Total Current Liabilities
3.20BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
647.29MUSDFY2025 · Dec 31, 2025Other Short-term Investments
0.00USDFY2025 · Dec 31, 2025Accounts Receivable
1.47BUSDFY2025 · Dec 31, 2025Accounts Payable
780.85MUSDFY2025 · Dec 31, 2025Short-term Debt
566.04MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.55BUSDFY2025 · Dec 31, 2025Other Current Liabilities
39.51MUSDFY2025 · Dec 31, 2025Long-term Debt
2.99BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
72.81MUSDFY2025 · Dec 31, 2025Common Stock (Book)
6.30MUSDFY2025 · Dec 31, 2025Retained Earnings
2.12BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
9.19BUSDvs all stocks (USD)
52-Week Low
66.57USDUpdated Jul 19, 202652-Week High
211.00USDUpdated Jul 19, 202652-Week Change
21.75%vs all stocks
Beta
1.22xvs all stocks
50-Day MA
142.83USDUpdated Jul 19, 2026200-Day MA
149.10USDUpdated Jul 19, 2026Avg 10-Day Volume
557.51KSharesUpdated Jul 19, 2026Avg 30-Day Volume
961.04KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
2.27USDUpdated Jul 19, 2026Other Income / Expense
-569.61MUSDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Asset Growth With a Recent Reversal
Assets grew over the long run on acquired goodwill, but have shrunk in each of four years.
Reads
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Multi-Year Cash Increase With FCF And Debt Decrease
Cash up four years running while long-term debt fell for three.
Reads
How does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.14×, lower than 95% of its Diagnostics & Research peers (median 2.76×)Significant
Current ratio: 1.14Industry median: 2.76Industry P5: 1.14Peers compared: 28.00
Price-to-book is 1.4×, lower than 95% of its Diagnostics & Research peers (median 3.52×)Notable
Price-to-book: 1.40Industry median: 3.52Industry P5: 1.51Peers compared: 28.00
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.06Revenue Growth YoY: 0.01
Financial Health
Altman Z-Score 1.91: grey zoneSignificant
Altman Z-Score: 1.91
High earnings qualityNotable
Earnings Quality Score: 0.86
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $13.11B, above the global median of $1.15BNotable
Market cap (USD): 13,114,714,260Global Median: 1,146,734,693.424
Revenue is $8.27B, above the global median of $520.53MNotable
Revenue (USD): 8,270,019,072Global Median: 520,528,949.311
Levered free cash flow is $809.34M, above the global median of $16.24MNotable
Levered free cash flow (USD): 809,339,264Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Crown Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Mowi ASA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Mueller Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nexchip Semiconductor Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Tempur Sealy International Inc.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
CNH Industrial N.V.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Dongfang Electric Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
IonQ, Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingInterface
Tata Motors Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Kinwong Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Genuine Parts Company
1 interpretationDepreciation-Heavy Reported Profit
Macy's Inc.
2 interpretationsCash-Backed Earnings ConfigurationDepreciation-Heavy Reported Profit
Arko Petroleum Corp.
3 interpretationsDrawdown With FCF And Cash BackingCash-Backed Earnings ConfigurationDepreciation-Heavy Reported Profit